Effects of insulin lispro mix 25 and insulin lispro mix 50 on postprandial glucose excursion in patients with type 2 diabetes: A prospective, open-label, randomized clinical trial
Diabetes Therapy Mar 17, 2018
Li W, et al. - This trial incorporated an inquiry of the effects of insulin lispro mix 25 (LM25) and insulin lispro mix 50 (LM50) on postprandial glucose excursion among subjects with type 2 diabetes mellitus (T2DM). Data exhibited that the LM50 regimen caused notably smaller postprandial glycemic excursions than the LM25 regimen. A better glycemic excursion control could be obtained after breakfast and dinner via LM50 compared to LM25 in T2DM patients.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries